Mild cognitive impairment affects more than 16 million people in America today, according to the Centers for Disease Control (CDC). This deterioration can range from mild to severe. Individuals suffering from mild cognitive impairment are plagued by problems related to memory and thinking skills. Despite the devastation caused by this condition, there is currently no drug approved to treat MCI. A new form of mild cognitive impairment treatment has emerged within the medical community. This promising new therapy is Transcranial Magnetic Stimulation (TMS).
What is Mild Cognitive Impairment?
According to Mayo Clinic, MCI is a brain function syndrome that encompasses problems dealing with memory, judgment and other cognitive functions. This problem is associated with advanced age, but the syndrome involves cognitive failings that are worse than should be expected at the patient’s age, but not yet serious enough to be classified as dementia.
Mild cognitive impairment can be devastating for the individual affected by it, often causing depression and anxiety. Although it is termed as “mild” cognitive impairment, MCI is a serious condition that affects the everyday life of the affected individual. As such, MCI is an important area in need of extensive and immediate medical research. Studies are currently being conducted on the efficacy of deep TMS for improving mild cognitive impairment with the hypothesis that TMS can improve symptoms of MCI.
What is TMS?
Transcranial magnetic stimulation was approved by the FDA in 2008 as a safe and effective treatment for major depression, proving its efficacy as a brain stimulation therapy. TMS is safe, painless and non-invasive, making it an appealing option for treating brain disorders. This medical discovery has prompted researchers to explore further applications of TMS.
TMS is administered to the patient through electromagnetic coils that are attached to the head. The patient sits comfortably for 30 minutes to an hour while electric currents stimulate nerve endings in the brain that are involved in cognitive function.
One application of TMS that is exciting the medical community is the use of TMS as a treatment for mild cognitive impairment. Studies are currently being conducted across the country on the use of TMS on patients with mild cognitive impairment.
How can TMS improve Mild Cognitive Impairment?
One reason why TMS has been indicated as a mild cognitive impairment treatment is that it has been shown to improve associative memory in healthy individuals. According to ALZ Forum, TMS improves memory in these individuals by strengthening pathways between the hippocampus and other brain regions.
Recent studies are promising for those seeking mild cognitive impairment treatment as they have shown that TMS had eradicated at least one psychological measure of impairment. The success of these studies indicates that increased research is needed into the use of TMS as an MCI treatment.
Mild cognitive impairment is a crushing syndrome plaguing elderly Americans. However, there may be relief for those suffering from MCI on the horizon. TMS is proving to be a safe and effective option for mild cognitive impairment treatment. Westside Neurotherapeutics offers Los Angeles clinical trials involving TMS therapy for OCD. For more information, contact Westside Neurotherapeutics by phone at 310.946.0008 or email us at firstname.lastname@example.org.